2. Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014; 20:23–30. DOI:
10.1016/j.ijid.2013.11.018. PMID:
24412314.
Article
3. Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of postherpetic neuralgia in Korea: an electronic population health insurance system based study. Medicine (Baltimore). 2016; 95:e3304. DOI:
10.1097/MD.0000000000003304. PMID:
27057902. PMCID:
PMC4998818.
4. Kim HJ, Ahn HS, Lee JY, Choi SS, Cheong YS, Kwon K, et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain. 2017; 30:3–17. DOI:
10.3344/kjp.2017.30.1.3. PMID:
28119767. PMCID:
5256258.
Article
5. Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician. 2012; 15:467–74. PMID:
23159962.
6. Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 2009; 109:1651–5. DOI:
10.1213/ANE.0b013e3181b79075. PMID:
19713253.
Article
8. Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology. 2016; 87:94–102. DOI:
10.1212/WNL.0000000000002808. PMID:
27287218. PMCID:
4932239.
Article
9. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med. 2004; 29:454–61. PMID:
15372391.
Article
10. Reichelt M, Zerboni L, Arvin AM. Mechanisms of varicellazoster virus neuropathogenesis in human dorsal root ganglia. J Virol. 2008; 82:3971–83. DOI:
10.1128/JVI.02592-07. PMID:
18256143. PMCID:
2292995.
Article
12. Van Zundert J, Hartrick C, Patijn J, Huygen F, Mekhail N, van Kleef M. Evidence-based interventional pain medicine according to clinical diagnoses. Pain Pract. 2011; 11:423–9. DOI:
10.1111/j.1533-2500.2011.00490.x. PMID:
21923721.
Article
13. Kim ED, Bak HH, Jo DH, Park HJ. Clinical efficacy of transforaminal epidural injection for management of zoster-associated pain: a retrospective analysis. Skeletal Radiol. 2018; 47:253–60. DOI:
10.1007/s00256-017-2795-2. PMID:
29051967.
Article
14. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008; 5(1 Suppl):S37–44. DOI:
10.1016/j.jpain.2007.10.008. PMID:
18166464.
Article
15. Kim YJ, Lee CN, Lee MS, Lee JH, Lee JY, Han K, et al. Recurrence rate of herpes zoster and its risk factors: a population-based cohort study. J Korean Med Sci. 2018; 34:e1. DOI:
10.3346/jkms.2019.34.e1. PMID:
30636941. PMCID:
PMC6327089.
Article
16. Vassiliev D. Spread of contrast during L4 and L5 nerve root infiltration under fluoroscopic guidance. Pain Physician. 2007; 10:461–6. PMID:
17525780.